🇺🇸 FDA
Patent

US 10583134

Methods and therapeutic combinations for treating tumors

granted A61KA61K2039/505A61K31/4745

Quick answer

US patent 10583134 (Methods and therapeutic combinations for treating tumors) held by The Board of Regents of the University of Texas expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61K31/4745, A61K39/395, A61K39/39558